These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers. Elnachef N; Scheiman JM; Fendrick AM; Howden CW; Chey WD Aliment Pharmacol Ther; 2008 Nov; 28(10):1249-58. PubMed ID: 18729848 [TBL] [Abstract][Full Text] [Related]
6. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer. Sandler RS Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132 [TBL] [Abstract][Full Text] [Related]
7. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381 [TBL] [Abstract][Full Text] [Related]
8. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II. Moyad MA Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882 [TBL] [Abstract][Full Text] [Related]
9. Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence. Silva MT; Galvao TF; Zimmerman IR; Pereira MG; Lopes LC Curr Pharm Des; 2012; 18(26):4047-70. PubMed ID: 22632754 [TBL] [Abstract][Full Text] [Related]
10. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I. Moyad MA Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881 [TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Rostom A; Dubé C; Lewin G; Tsertsvadze A; Barrowman N; Code C; Sampson M; Moher D; Ann Intern Med; 2007 Mar; 146(5):376-89. PubMed ID: 17339623 [TBL] [Abstract][Full Text] [Related]
12. Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway. Slattery ML; Samowitz W; Hoffman M; Ma KN; Levin TR; Neuhausen S Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):538-45. PubMed ID: 15066917 [TBL] [Abstract][Full Text] [Related]
13. NSAIDS and gastrointestinal cancer. Piazuelo E; Lanas A Prostaglandins Other Lipid Mediat; 2015 Jul; 120():91-6. PubMed ID: 26093284 [TBL] [Abstract][Full Text] [Related]
14. Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study. García Rodríguez LA; Huerta-Alvarez C Epidemiology; 2000 Jul; 11(4):376-81. PubMed ID: 10874542 [TBL] [Abstract][Full Text] [Related]
15. Vascular effects of nonsteroidal antiinflammatory drugs. Soubrier M; Rosenbaum D; Tatar Z; Lahaye C; Dubost JJ; Mathieu S Joint Bone Spine; 2013 Jul; 80(4):358-62. PubMed ID: 23796731 [TBL] [Abstract][Full Text] [Related]
16. Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals. Martínez ME; McPherson RS; Levin B; Annegers JF Cancer Epidemiol Biomarkers Prev; 1995; 4(7):703-7. PubMed ID: 8672985 [TBL] [Abstract][Full Text] [Related]
17. Aspirin-sensitive asthma: abnormal platelet response to drugs inducing asthmatic attacks. Diagnostic and physiopathological implications. Ameisen JC; Capron A; Joseph M; Maclouf J; Vorng H; Pancré V; Fournier E; Wallaert B; Tonnel AB Int Arch Allergy Appl Immunol; 1985; 78(4):438-48. PubMed ID: 3934085 [TBL] [Abstract][Full Text] [Related]